MAP Pharmaceuticals Inc.

Maker of inhaled-drug products prices at $12, gains 16%

1 December 2007•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.